Tag: Diabetes: Misc.
1990 to 2021 Saw Increase in Global Burden of Diabetic Nephropathy
Burden is projected to continue increasing through 2050, and is related to sociodemographic index
No Weight Loss Benefit Seen for Neoadjuvant Semaglutide Before Weight Loss Surgery
No benefits seen in terms of weight loss, diabetes remission, surgery safety
Recent Decade Saw No Change in Diabetes Prevalence in U.S. Adults
However, glycemic control worsened, with the trend most pronounced among younger adults aged 20 to 44 years
Continuous Glucose Monitors Overestimate Glycemic Responses
Variation in CGM bias by postprandial test, with glycemic index for commercial fruit smoothie higher with CGM versus capillary sampling
One-Hour Glucose on OGTT at Three Months Postpartum Predicts Dysglycemia
One-hour glucose was strongest predictor of dysglycemia on regression analyses, followed by two-hour glucose
FDA Approves First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
Merilog administered subcutaneously five to 10 minutes before mealtime helps improve glycemic control
Wrong Smartphone Settings Can Lead to Missed Alerts From Linked Diabetes Devices
Hardware and software changes, updates, and configurations can result in undelivered critical safety alerts
FDA Approves Susvimo for Diabetic Macular Edema
Approval marks the first and only continuous delivery treatment as an alternate to regular eye injections
Fasting Glucose, Age, Male Sex, BMI All Linked to Diabetes Development
Initial fasting plasma glucose levels outside of 80 to 94 mg/dL linked to increased risk for diabetes
Continuous Glucose Monitoring Can Predict Microvascular Complications in Type 1 Diabetes
Time-in-range computed from virtual CGM data predicts retinopathy, neuropathy similarly to glycated hemoglobin data
